Mini Nutritional Assessment (MNA) and biochemical markers of cachexia in metastatic lung cancer patients: Interrelations and associations with prognosis

Lung Cancer

Volumn 74, Issue 3, 2011, Pages 516-520

  Gioulbasanis, Ioannis ^a,b   Georgoulias, Panagiotis ^b   Vlachostergios, Panagiotis J ^b   Baracos, Vickie ^c   Ghosh, Sunita ^c   Giannousi, Zoe ^a   Papandreou, Christos N ^b   Mavroudis, Dimitris ^a   Georgoulias, Vassilis ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^b UNIVERSITY HOSPITAL OF LARISSA   (Greece)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Biomarkers; Cachexia; Inflammation; Lung cancer; Mini Nutritional Assessment; Non small cell lung cancer; Prognosis

Indexed keywords

ADIPONECTIN; ALBUMIN; BIOCHEMICAL MARKER; C REACTIVE PROTEIN; GHRELIN; HEMOGLOBIN; LEPTIN; SOMATOMEDIN C;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; CACHEXIA; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; METASTASIS; MINI NUTRITIONAL ASSESSMENT; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; WEIGHT REDUCTION;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CACHEXIA; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PNEUMONIA;

EID: 80054940988     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2011.05.009     Document Type: Article

References (44)

1. Muscaritoli M., Bossola M., Aversa Z., Bellantone R., Rossi Fanelli F. Prevention and treatment of cancer cachexia: new insights into and old problem. Eur J Cancer 2006, 42:31-41.
2. MacDonald N., Easson A.M., Mazurak V.C., Dunn G.P., Baracos V.E. Understanding and managing cancer cachexia. J Am Coll Surg 2003, 197:143-161.
3. Huhmann M.B., Cunningham R.S. Importance of nutritional screening in treatment of cancer-related weight loss. Lancet Oncol 2005, 6:334-343.
4. Guigoz Y., Vellas B., Garry P.J. Assessing the nutritional status of the elderly: the Mini Nutritional Assessment as part of the geriatric evaluation. Nutr Rev 1996, 54:S59-S65.
5. Extermann M., Hurria A. Comprehensive geriatric assessment for Older Patients with Cancer. Clin Oncol 2007, 25:1824-1831.
6. Tisdale M. Mechanisms of cancer cachexia. Physiol Rev 2009, 89:381-410.
7. Falconer J.S., Fearon K.C., Ross J.A., Elton R., Wigmore S.J., Garden O.J., et al. Acute-phase protein response and survival duration of patients with pancreatic cancer. Cancer 1995, 75:2077-2082.
8. DeBoer M.D., Zhu X.X., Levasseur P., Meguid M.M., Suzuki S., Inui A., et al. Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia. Endocrinology 2007, 148:3004-3012.
9. Costelli P., Muscaritoli M., Bossola M., Penna F., Reffo P., Bonetto A., et al. IGF-1 is downregulated in experimental cancer cachexia. Am J Physiol Regul Integr Comp Physiol 2006, 291:R674-R683.
10. Penna F., Bonetto A., Muscaritoli M., Costamagna D., Minero V.G., Bonelli G., et al. Muscle atrophy in experimental cancer cachexia: is the IGF-1 signaling pathway involved?. Int J Cancer 2010, 127:1706-1717.
11. Wolf I., Sadetzki S., Kanety H., Kundel Y., Pariente C., Epstein N., et al. Adiponectin, ghrelin and leptin in cancer cachexia in breast and colon cancer patients. Cancer 2006, 106:966-973.
12. Fearon K.C. Cancer cachexia: developing multimodal therapy for a multidimensional problem. Eur J Cancer 2008, 44:1124-1132.
13. Gioulbasanis I., Baracos V., Giannousi Z., Xyrafas A., Martin L., Georgoulias V., et al. Baseline nutritional evaluation in metastatic lung cancer patients: mini nutritional assessment (MNA) versus weight loss history. Ann Oncol 2010, [Epub ahead of print].
14. Martín F., Santolaria F., Batista N., Milena A., González-Reimers E., Brito M.J., et al. Cytokine levels (IL-6 and IFN-gamma), acute phase response and nutritional status as prognostic factors in lung cancer. Cytokine 1999, 11:80-86.
15. Argilés J.M., López-Soriano F.J., Busquets S.A. Novel approaches to the treatment of cachexia. Drug Discov Today 2008, 13:73-78.
16. Vellas B., Guigoz Y., Garry P.J., Nourhashemi F., Bennahum D., Lauque S., et al. The Mini Nutritional Assessment (MNA) and its use in grading the nutritional state of elderly patients. Nutrition 1999, 15:116-122.
17. Pirlich M., Lochs H. Nutrition in the elderly. Best Pract Res Clin Gastroenterol 2001, 15:869-884.
18. Bauer J.M., Kaiser M.J., Sieber C.C. Sarcopenia in nursing home residents. J Am Med Dir Assoc 2008, 9:545-551.
19. Salva A., Coll-Planas L., Bruce S., De Groot L., Andrieu S., Abellan G., et al. Nutritional assessment of residents in long-term care facilities (LTCFs): recommendations of the task force on nutrition and ageing of the IAGG European region and the IANA. J Nutr Health Aging 2009, 13:475-483.
20. Toliusiene J., Lesauskaite V. The nutritional status of older men with advanced prostate cancer and factors affecting it. Support Care Cancer 2004, 12:716-719.
21. Slaviero K.A., Read J.A., Clarke S.J., Rivory L.P. Baseline nutritional assessment in advanced cancer patients receiving palliative chemotherapy. Nutr Cancer 2003, 46:148-157.
22. Schiffman S.S., Sattely-Miller E.A., Taylor E.L., Graham B.G., Landerman L.R., Zervakis J., et al. Combination of flavor enhancement and chemosensory education improves nutritional status in older cancer patients. J Nutr Health Aging 2007, 11:439-454.
23. Saka B., Kaya O., Ozturk G.B., Erten N., Karan M.A. Malnutrition in the elderly and its relationship with other geriatric syndromes. Clin Nutr 2010, [Epub ahead of print].
24. Lei Z., Qingyi D., Feng G., Chen W., Hock R.S., Changli W. Clinical study of mini-nutritional assessment for older Chinese inpatients. J Nutr Health Aging 2009, 13:871-875.
25. Venzin R.M., Kamber N., Keller W.C., Suter P.M., Reinhart W.H. How important is malnutrition? A prospective study in internal medicine. Eur J Clin Nutr 2009, 63:430-436.
26. Langkamp-Henken B., Hudgens J., Stechmiller J.K., Herrlinger-Garcia K.A. Mini nutritional assessment and screening scores are associated with nutritional indicators in elderly people with pressure ulcers. J Am Diet Assoc 2005, 105:1590-1596.
27. Alves de Rezende C.H., Marquez Cunha T., Alvarenga Júnior V., Penha-Silva N. Dependence of mini-nutritional assessment scores with age and some hematological variables in elderly institutionalized patients. Gerontology 2005, 51:316-321.
28. Soini H., Routasalo P., Lagstrom H. Nutritional status in cognitively intact older people receiving home care services-a pilot study. J Nutr Health Aging 2005, 9:249-253.
29. Vellas B., Guigoz Y., Baumgartner M., Garry P.J., Lauque S., Albarede J.L. Relationships between nutritional markers and the mini-nutritional assessment in 155 older persons. J Am Geriatr Soc 2000, 48:1300-1309.
30. Amirkalali B., Sharifi F., Fakhrzadeh H., Mirarefein M., Ghaderpanahi M., Badamchizadeh Z., et al. Low serum leptin serves as a biomarker of malnutrition in elderly patients. Nutr Res 2010, 30:314-319.
31. Bauer J.M., Wirth R., Troegner J., Erdmann J., Eberl T., Heppner H.J., et al. Ghrelin, anthropometry and nutritional assessment in geriatric hospital patients. Z Gerontol Geriatr 2007, 40:31-36.
32. Bonin-Guillaume S., Herrmann F.R., Boillat D., Szanto I., Michel J.P., Rohner-Jeanrenaud F., et al. Insulinemia and leptinemia in geriatric patients: markers of the metabolic syndrome or of undernutrition?. Diabetes Metab 2006, 32:236-243.
33. Morley J.E., Miller D.K., Perry H.M., Patrick P., Guigoz Y., Vellas B. Anorexia of aging, leptin, and the Mini Nutritional Assessment. Nestle Nutr Workshop Ser Clin Perform Programme 1999, 1:67-76.
34. Simons J.P., Schols A.M., Buurman W.A., Wouters E.F. Weight loss and low body cell mass in males with lung cancer: relationship with systemic inflammation, acute-phase response, resting energy expenditure, and catabolic and anabolic hormones. Clin Sci (Lond) 1999, 97:215-223.
35. Lazarus D.D., Kambayashi T., Lowry S., Strassmann G. The lack of an effect by insulin or insulin-like growth factor-1 in attenuating colon-2-mediated cancer cachexia. Cancer Lett 1996, 103:71-77.
36. Wang W., Iresjö B.M., Karlsson L., Svanberg E. Provision of rhIGF-I/IGFBP-3 complex attenuated development of cancer cachexia in an experimental tumor model. Clin Nutr 2000, 19:127-132.
37. Huang Q., Nai Y.J., Jiang Z.W., Li J.S. Change of the growth hormone-insulin-like growth factor-I axis in patients with gastrointestinal cancer: related to tumour type and nutritional status. Br J Nutr 2005, 93:853-858.
38. Paesmans M., Sculier J.P., Libert P., Bureau G., Dabouis G., Thiriaux J., et al. Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party. J Clin Oncol 1995, 3:1221-1230.
39. Paesmans M., Sculier J.P., Lecomte J., Thiriaux J., Libert P., Sergysels R., et al. Prognostic factors for patients with small cell lung carcinoma: analysis of a series of 763 patients included in 4 consecutive prospective trials with a minimum follow-up of 5 years. Cancer 2000, 89:523-533.
40. Sculier J.P., Chansky K., Crowley J.J., Van Meerbeeck J., Goldstraw P. The impact of additional prognostic factors on survival and their relationship with the anatomical extent of disease expressed by the 6th Edition of the TNM Classification of Malignant Tumors and the proposals for the 7th Edition. J Thorac Oncol 2008, 3:457-466. International Staging Committee and Participating Institutions.
41. Oh Y., Taylor S., Bekele B.N., Debnam J.M., Allen P.K., Suki D., et al. Number of metastatic sites is a strong predictor of survival in patients with nonsmall cell lung cancer with or without brain metastases. Cancer 2009, 115:2930-2938.
42. Paralkar V.R., Li T., Langer C.J. Population characteristics and prognostic factors in metastatic non-small-cell lung cancer: a Fox Chase Cancer Center retrospective. Clin Lung Cancer 2008, 9:116-121.
43. Alemán M.R., Santolaria F., Batista N., de La Vega M., González-Reimers E., Milena A., et al. Leptin role in advanced lung cancer, a mediator of the acute phase response or a mark of the status of nutrition. Cytokine 2002, 19:21-26.
44. Karapanagiotou E.M., Tsochatzis E.A., Dilana K.D., Tourkantonis I., Gratsias I., Syrigos K.N. The significance of leptin, adiponectin, and resistin serum levels in non-small cell lung cancer (NSCLC). Lung Cancer 2008, 61:391-397.